MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    GPi DBS for refractory dystonia 4 years after STN DBS on a Parkinson’s Disease patient

    B. Meira, A. Santos, C. Reizinho, R. Barbosa, M. Mendonça, P. Bugalho (Lisbon, Portugal)

    Objective: Describe a case of unilateral globus pallidus internus (GPi) deep brain stimulation (DBS) for refractory dystonia after subthalamic nucleus (STN) DBS on a Parkinson…
  • MDS Virtual Congress 2021

    Measures of Physical Activity in Parkinson’s Disease (MAPD)

    J. Gilby, C. Carroll, J. Marsden (Plymouth, United Kingdom)

    Objective: This study assessed the concurrent validity, feasibility and perceived utility of two different modalities of capturing physical activity (PA) in people with newly diagnosed…
  • MDS Virtual Congress 2021

    A metadata-driven tool to determine the robustness of digital health technologies assessments for Parkinson’s disease leveraging the voice of the patient

    S. Sardar, R. Bhatnagar, R. Badawy, J. Burton, V. Aggarwal, K. Romero, M. Minchik, M. Spott, D. Hill, J. Cosman, C. Lansdall, G. Stebbins, N. Zach, M. Frasier, T. Hastings, M. Javidnia, J. Duffen, H. Matthews, M. Lawton, D. Dexter, N. Ratcliffe, K. Fisher, L. Oliva, S. Jones, A. Dowling, M. Meinders, L. Evers, B. Bloem, J. Cedarbaum, M. Muller, D. Stephenson (Tucson, USA)

    Objective: To develop a decision tool for assessing the robustness of digital health technology (DHT)-based measures in Parkinson’s disease (PD) using  a patient-centric approach. Background: Development of effective therapeutics in PD is hampered by the lack of drug development…
  • MDS Virtual Congress 2021

    Engage-PD: a Physical Activity Coaching Program via Telehealth for people with Parkinson’s Disease – Preliminary results a year after inception.

    C. Macpherson, M. King, H. Shih, J. Rieger, J. Fineman, J. Reid, A. Pacheco, H. Shah, R. Alcalay, L. Quinn (New York City, USA)

    Objective: The purpose of this study was to evaluate effects of a telehealth (TH) coaching program to promote physical activity (PA) in people with Parkinson’s…
  • MDS Virtual Congress 2021

    Overview of the population of patients with advanced Parkinson’s disease (aPD) initiating therapy with levodopa-carbidopa intestinal gel (LCIG): POMPE-PARK study on French health insurance data (2013-2017)

    JP. Azulay, D. Grabli, S. Benard, N. Kabore, MS. Behier (Marseille, France)

    Objective: To quantify the number of French aPD patients initiating continuous delivery of LCIG from 2013 to 2017 and to describe their demographic, clinical and…
  • MDS Virtual Congress 2021

    Mortality of people with Parkinson’s disease in a large population-based cohort study. Time trends and relationship to disease progression.

    O. Okunoye, L. Horsfall, L. Marston, K. Walters, A. Schrag (London, United Kingdom)

    Objective: To explore how PD mortality rates have changed over time and their relationship to disease progression, age, gender and social deprivation using a large…
  • MDS Virtual Congress 2021

    Sleep Quality and Nutrition effects in patients with Parkinson’s Disease

    C. López Botello, A. Pérez Arzola, B. Chávez Luevanos, S. Castillo Torres, D. Martínez Roque, I. Estrada Bellmann (Monterrey, Mexico)

    Objective: Establish the relationship between nutritional indicators and sleep quality index in patients with Parkinson disease. Background: One of the most frequent non-motor symptoms of…
  • MDS Virtual Congress 2021

    Happy to be home: Satisfaction with interdisciplinary home visits among individuals with advanced Parkinson’s Disease and their caregivers

    J. Fleisher, K. Woo, M. Levin, S. Hess, F. Akram, B. Ouyang, D. Hall, J. Chodosh (Chicago, USA)

    Objective: To compare satisfaction with medical care among people with advanced Parkinson’s Disease (PD) and their caregivers at baseline (best usual care in a tertiary…
  • MDS Virtual Congress 2021

    Evaluation of Motor Function Using Motor Testing App and Deep Learning for the Treatment of Lewy Body Dementia

    X. Dang, Y. Guan, K. Deng, J. Wang, H. Zhang, C. Battioui, M. Pugh, B. Winger, J. Yang, K. Biglan (Cambridge, USA)

    Objective: To construct deep learning (DL) models using finger tapping data and apply them in PRESENCE to evaluate treatment effect in motor function. Background: PRESENCE…
  • MDS Virtual Congress 2021

    Re-thinking enrollment of Deep Brain Stimulation patients in Parkinson’s Disease Clinical Trials

    J. Jimenez-Shahed, J. Rosenow, S. Miocinovic, L. Luo, C. Aquino, D. Corcos, P. Agarwal (New York, USA)

    Objective: To report on a survey of Parkinson’s disease (PD) experts on the inclusion of PD patients with deep brain stimulation (DBS) in clinical trials.…
  • « Previous Page
  • 1
  • …
  • 388
  • 389
  • 390
  • 391
  • 392
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley